Nav: Home

Most liver transplant candidates receive donation offers

October 22, 2012

Most liver transplant candidates who died or were removed from the transplant list actually received one or more liver donation offers, according to a recent UCSF study.

"What we found challenges the simplistic view that transplant dynamics are driven simply by organ availability," said lead author, Jennifer Lai, MD, assistant clinical professor in the UCSF Division of Gastroenterology and Hepatology. "Efforts to reduce wait-list mortality must target all aspects of mismatch between supply and demand."

The research team analyzed data from 33,389 candidates listed in the United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) registry during the time frame of Feb. 1, 2005 to Jan. 31, 2010. Out of the candidates who had died or been delisted, 84 percent received one or more liver offers prior to death/delisting, indicating that they had an opportunity to undergo transplantation. Reasons for liver offer refusals were reported as donor quality/age or other donor-related factors, size compatibility or recipient readiness.

"Understanding the real-time factors involved in the decisions regarding liver transplant offers is vital to improving the wait-list process," said senior author, John Roberts, MD, professor of surgery and chief of the UCSF Division of Transplantation. "While some of the factors are beyond control, others can be managed."

Simply increasing the availability of deceased donor livers or the number of offers may not necessarily reduce wait-list mortality, according to the study. Instead, the study suggests that efforts must be made to understand multiple factors involving candidates, donors and transplant centers to help influence what is often a complex and dynamic decision to accept or decline a liver offer.

More specifically, the study recommends that wait-list candidates efficiently complete their pre-transplant evaluations so they are ready for liver offers as soon as possible. Patients with a Model of End-stage Liver Disease (MELD) score of 15 or higher also should be thoroughly educated about the survival benefit of transplantation with any liver graft, as opposed to continued waiting. The MELD is a scoring system for assessing the severity of chronic liver disease and is used by UNOS for prioritizing allocation of liver transplants.

The team also suggests improving efforts within the transplant community to reduce the stigma associated with non-ideal livers and setting realistic expectations for wait-listed candidates regarding the available donor organs.

"The decision to accept a liver offer is not just about minimizing complications after transplant, but about reducing the unpredictability of death before transplant," Lai said.
-end-
Sandy Feng, MD, PhD, professor of surgery in the UCSF Division of Transplant Surgery and director of the UCSF Abdominal Transplant Fellowship Program, is a co-author.

Funding for this research was provided by the National Institute of Diabetes and Digestive and Kidney Diseases and the UCSF Liver Center. The paper was published in the leading journal in its field, Gastroenterology.

Recognized as a world leader in organ transplantation since 1964, the UCSF Organ Transplant Service has performed transplants for more than 10,000 patients and has played a key role in defining the field. The UCSF Liver Transplant Program, designated as a "Center of Excellence" by the U.S. Department of Health and Human Services performs more liver transplants than any other hospital in Northern California - over 2,300 liver transplants for adults and children since it began in 1988.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Follow UCSF

UCSF.edu | Facebook.com/ucsf | Twitter.com/ucsf | YouTube.com/ucsf

University of California - San Francisco

Related Transplantation Articles:

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.
Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.
Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.
Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.
Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.
More Transplantation News and Transplantation Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...